Status:

COMPLETED

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

Lead Sponsor:

Sandoz

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

To demonstrate the relative bioavailability study of Ramipril 10 mg capsules under non-fasting conditions.

Eligibility Criteria

Inclusion

  • No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion

  • Positive test results for HIV or hepatitis B or C.
  • Treatment for drug or alcohol dependence.

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2004

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT00946621

Start Date

October 1 2004

End Date

November 1 2004

Last Update

March 28 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.